A New Era for Mass-Spectrometry-Based Proteomics
In a groundbreaking achievement, MOBILion Systems has demonstrated a remarkable technical milestone, fundamentally changing mass-spectrometry-based proteomics. The company's proof-of-concept for high-resolution ion mobility (HRIM) showcases its innovative PAMAF mode, setting a new standard for efficient and effective proteomic analysis.
Addressing Long-standing Limitations in Proteomics
For over 25 years, experts have recognized a significant shortcoming in LC-MS/MS proteomics workflows — the inefficiency of ion utilization. As the complexity of analysis increases, this limitation becomes even more pronounced. Despite the advancements in both instruments and software, the field has remained bogged down with only minor improvements over time. Yet, in a bold move, MOBILion proposed to overturn this dated paradigm by introducing PAMAF as a fresh operational model enabled by its revolutionary high-resolution ion mobility platform.
Pioneering a Shift from Theory to Reality
Following the release of their technical white paper, MOBILion wasted no time in turning theory into practice. The team has built a unique prototype and established a Proteomics Advisory Board for insightful external validation. Throughout the year, they've produced significant results, including several peer-reviewed publications and studies conducted by independent collaborators, demonstrating that their innovative technologies meet the pressing need for improved acquisition rates in proteomic workflows.
Transforming Proteomics and Multiomics Workflows
MOBILion’s technology uniquely overcomes the historical challenges regarding sensitivity and speed in conventional proteomics. With the ability to analyze more proteins and post-translational modifications in less time than traditional systems, the results have transformative implications for drug development and biomarker discovery, resulting in deeper biological understandings.
Innovative Solutions for Unmet Needs
As the findings from MOBILion’s research highlight, many of the limitations tied to conventional mass spectrometry cannot simply be remedied through software enhancements or minor hardware tweaks. Instead, the HRIM-enabled PAMAF operation presents a distinct solution, paving the way for capabilities that existing platforms simply cannot achieve without a complete redesign.
MOBILion's Vision for the Future
MOBILion plans to expand its high-resolution ion mobility technology across various segments of the mass spectrometry ecosystem. They aim to integrate their systems not just in proteomics, but also into metabolomics, lipidomics, exposomics, and additional analytical markets where high value is generated.
A Strong Position in the Market
The strategic advantages of MOBILion Systems are rooted in its unique assets that are complex to replicate. Their intellectual property portfolio is solid, safeguarding both innovative technology and proprietary operating modes, all while nurturing a loyal base of collaborators who increasingly rely on their platform for advancing their research needs.
An Evolving Leader in Mass Spectrometry
With the validation of technical feasibility within proteomics, which is recognized as the largest and most demanding sector of the high-resolution mass spectrometry market, MOBILion is now positioned to fulfill essential requirements in existing workflows. These include achieving deeper proteome coverage and the confident identification of low-abundance species and post-translational modifications at higher throughput rates.
Conclusion: A Future Driven by Innovation
MOBILion Systems, Inc. is at the forefront of a significant evolution in the scientific understanding of separation science. Their proprietary SLIM technology enables faster and more precise characterization of complex molecules, making it a valuable asset across a spectrum of sectors such as biopharma, metabolomics, and environmental safety.
Frequently Asked Questions
What is MOBILion Systems known for?
MOBILion Systems is recognized for its innovative technologies in mass spectrometry, particularly using high-resolution ion mobility for proteomics.
How does PAMAF mode benefit proteomics?
PAMAF mode addresses long-standing inefficiencies in conventional workflows, improving sensitivity and speed, thereby allowing more effective analysis.
What are the key market areas for MOBILion's technology?
MOBILion’s technology is expanding beyond proteomics into metabolomics, lipidomics, and other analytical markets.
Who is the CEO of MOBILion Systems?
The CEO of MOBILion Systems is Melissa Sherman, PhD, who is instrumental in guiding the company’s innovative direction.
How can researchers utilize MOBILion Systems’ instruments?
MOBILion's instruments empower researchers across a variety of disciplines, facilitating faster and more reliable analyses in their work.
